Stokes–Adams syndrome is a periodic fainting spell in which there is a intermittent heart block due to an arrhythmia that may last for seconds, hours, days, or even weeks before the conduction returns. Named after two Irish physicians, Robert Adams (1791–1875) and William Stokes (1804–1877), the first description of the syndrome was published in 1717 by the Carniolan physician of Slovene descent Marko Gerbec, which was 44 years after its publication quoted by Giovanni Battista Morgagni. It is characterized by decrease in cardiac output and loss of consciousness due to a transient arrhythmia; for example, bradycardia due to complete heart block.
|Other names||Adams–Stokes syndrome, Gerbezius–Morgagni–Adams–Stokes syndrome and Gerbec–Morgagni–Adams–Stokes syndrome|
Signs and symptoms
Typically an attack occurs without warning, leading to sudden loss of consciousness. Prior to an attack, a patient may be pale with hypoperfusion. Normal periods of unconsciousness last approximately thirty seconds; if abnormal movements are present, they will consist of twitching after 15–20 seconds (the movements, which are not seizures, occur because of brainstem hypoxia and not due to cortical discharge, as evident from EEG findings, which show no epileptiform activities). Breathing continues normally throughout the attack, and, upon recovery, the patient becomes flushed as the heart rapidly pumps the oxygenated blood from the pulmonary beds into the systemic circulation, which has become dilated due to hypoxia.
As with any syncopal episode that results from a cardiac dysrhythmia, the fainting does not depend on the patient's position. If they occur during sleep, the presenting symptom may simply be feeling hot and flushed on waking.
The attacks are caused by any temporary lack of cardiac output. This in turn could be due to any number of causes, including antimony poisoning, cardiac asystole, heart block, Lev's disease or ventricular fibrillation. Paroxysmal supraventricular tachycardia or atrial fibrillation is the underlying cause in up to 5% of patients. The resulting lack of blood flow to the brain is responsible for the faint.
Stokes-Adams attacks may be diagnosed from the history, with paleness prior to the attack and flushing after it particularly characteristic. The ECG will show asystole, an AV block, or ventricular fibrillation during the attacks.
Initial treatment can be medical, involving the use of drugs like isoprenaline (Isuprel) and epinephrine (adrenaline). Definitive treatment is surgical, involving the insertion of a pacemaker – most likely one with sequential pacing such as a DDI mode as opposed to the older VVI mechanisms, and the doctor may arrange the patient to undergo electrocardiography to confirm this type of treatment.
If undiagnosed (or untreated), Stokes–Adams attacks have a 50% mortality within a year of the first episode. The prognosis following treatment is very good.
- synd/1158 at Who Named It?
- R. Adams. Cases of Diseases of the Heart, Accompanied with Pathological Observations. Dublin Hospital Reports, 1827, 4: 353–453.
- W. Stokes. Observations on some cases of permanently slow pulse. Dublin Quarterly Journal of Medical Science, 1846, 2: 73–85.
- "Stokes-Adams; Adams-Stokes; Morgagni-Adams-Stokes Attacks". patient.info.
- Katz, Jason; Patel, Chetan (2006). Parkland Manual of Inpatient Medicine. Dallas, TX: FA Davis. p. 903.
- ADams and victor's principles of neurology
- Chart 63: "Faintness and Fainting", page 161, ISBN 0-86318-864-8